- Category: Products
Products
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
First and only combination drop of carbachol and brimonidine tartrate achieves miosis within 30 minutes and lasts up to 10 hours following once-daily dosing.Products
FDA approves Glaukos' iDose TR for repeat treatment labeling
Travoprost intracameral implant can now be re-administered using a repeat treatment protocol—enabling greater flexibility in glaucoma patient management.Products
FDA approves Alembic's difluprednate 0.05% generic
Generic version of Sandoz’s Durezol is indicated for postop pain and inflammation as well as endogenous anterior uveitis.Products
Nidek launches Phantom Open-field Refraction System
Device corrects refractive errors with virtual lenses simulating the same properties as real lenses—in under 5 minutes.Products
OCuSOFT launches Retaine Omega Forte for dry eye
New nutritional supplement offers a daily dose of omega-3 essential fatty acids.Products
Focus Vitamins launches PF artificial tears for dry eye
Manufactured by cGMP- and NSF-certified suppliers, Focus Tears PF Eye Drops are formulated with CMC sodium 0.5% to offer temporary ocular relief.Products
WAVE Lens Designer Software integrates with Topcon MYAH
Integration enables direct import of corneal topography data into custom lens platform, streamlining the specialty contact lens design workflow.Products
Dr. Reddy's olopatadine HCl 0.7% launches as first-to-market generic
The OTC eye drop is a bioequivalent to Alcon’s Once Daily Extra Strength, with ocular allergy relief lasting 24 hours.Products
FDA clears Rayner's Sophi phacemulsification system
First battery-powered, wireless phaco system features triple pump fluidics for more control of anterior chamber stability during cataract surgery.Products
FDA approves Gland Pharma's OTC Extra Strength Pataday generic
Olopatadine HCl ophthalmic solution 0.7% is indicated to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander for 24 hours.Products
Euclid Vision launches new SiHy daily disposable lens for myopia
The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.Products
FDA clears first EDOF contact lens for presbyopia
U.S. approval is first for a daily disposable, extended-depth-of-field lens requiring no patient cognitive adaptation period for presbyopia correction.Products
FDA approves Formycon and Bioeq's Lucentis biosimilar
Nufymco (ranibizumab-leyk) marks the companies’ second ranibizumab biosimilar cleared in the U.S. to treat five retinal indications.Products
Your rundown: 2025 approvals and launches
Take a trip down memory lane for a look at this year’s latest additions to the ophthalmic space.Products
Rinsada expands irrigating eyelid retractor distribution to Canada
Already FDA-cleared in the U.S., the medical device is now registered by Health Canada and only available through online retailer Eye Drop Shop.Products
FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension
Generic of Bausch + Lomb’s ZYLET for steroid-responsive inflammatory ocular conditions qualifies for 6 months of market exclusivity once commercially launched.Products
Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief
Clinical experts share OD-MD insights into the advanced artificial tears’ hydrating PF formulation with active glycerin and hyaluronic acid.Products
Amneal receives FDA approval for Restasis generic
Generic version of Allergan’s cyclosporine ophthalmic emulsion 0.05% eye drop for dry eye is the second to receive U.S. regulatory clearance.Products
Evoq launches FDA-registered dark adaptation testing device for IRDs
The Twilight is a wearable and smartphone-based diagnostic tool for at-home, remote monitoring of retinal health and early retinal disease detection.Products